Digoxin
FDA Approved
Description
Digoxin is a cardiac glycoside used to treat heart failure and atrial arrhythmias. It increases myocardial contractility and is sometimes used in managing complications of cardiac tumors. The drug has been in clinical use for decades with well-established safety profiles.
Indications & Therapeutic Use
Heart failure, atrial fibrillation, atrial flutter, cardiac arrhythmias
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Digoxin
| Generic Name | Digoxin |
| Brands | 1 brand available |
| Active Ingredient | Digoxin |
| Drug Class | Heart failure |
| Manufacturer | Aspen Pharma |
| Dosage Forms | Oral tablets 0.125mg, 0.25mg; IV injection 0.25mg/mL |
| Medical Code | C01AA05 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes